Holen Sie sich die Stockscreener-App
1.64
6.82%
-0.12
Handel nachbörslich:
1.61
-0.03
-1.83%
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.20%
18.67
|
19.90 | 20.12 | 19.69 | 22.65 |
| Operating Income/Loss |
6.20%
-18.67
|
-19.90 | -20.12 | -19.69 | -22.65 |
| Nonoperating Income/Loss |
18.14%
0.704
|
0.86 | 1.131 | 1.453 | 1.643 |
| Net Income/Loss |
5.66%
-17.96
|
-19.04 | -18.98 | -18.23 | -21.01 |
| Basic Average Shares |
8.05%
41.84
|
38.72 | - | 38.56 | 38.46 |
| Diluted Average Shares |
8.05%
41.84
|
38.72 | - | 38.56 | 38.46 |
| Basic Earnings Per Share |
12.24%
-0.43
|
-0.49 | - | -0.47 | -0.55 |
| Diluted Earnings Per Share |
12.24%
-0.43
|
-0.49 | - | -0.47 | -0.55 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):